The Swiss stock market rose slightly on Thursday after moving in a narrow area above the flat line throughout the day’s session.
The mood was cautious as investors were looking for clues in the direction.Concerns about Coronavirus While optimism about the potential Covid-19 vaccine prevented slipping, cases and economic growth continued to weigh heavily.
Benchmark SMI, which moved between 10,494.69 and a high of 10,524.82, ended the day at 10,497.79 with a slight increase of 9.52 points or 0.09%.
Seeka rose just over 1%, but Roche Holding ended nearly 1%. Givaudan, Nestle and Novartis made modest profits.
Zurich Insurance Group’s share price fell 1.4%. Richemont, Credit Suisse, UBS Group, Swatch Group, Swiss Life Holding, Swiss Re, Geberit and SGS lost 0.5-1%.
Among the shares in the Swiss Mid-Price Index, SIG Combibloc rose 3.4%, Logitech rose 2.25% and Tecan Group rose 2%. Sonova, Dufry, OC Oerlikon Corp, Temenos Group, Vifor Pharma, Kuehne & Nagel and Gerog Fischer also rose significantly.
Adecco, Helvetia, Baloise Holding and Cembra Money Bank fell.
With the Covic-19 update, the number of new cases in Switzerland increased by 4,509 on Thursday, less than the previous day’s 4,876 cases. In Switzerland, 85 people died on Wednesday, while 58 new people died from a coronavirus infection on Thursday.
Contact for comments and feedback: firstname.lastname@example.org
Swiss market ends at slightly higher
Source link Swiss market ends at slightly higher